These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29076000)

  • 1. Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study.
    Cather JC; Ryan C; Meeuwis K; Potts Bleakman AJ; Naegeli AN; Edson-Heredia E; Poon JL; Jones C; Wallace AN; Guenther L; Fretzin S
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):447-461. PubMed ID: 29076000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health.
    Gottlieb AB; Kirby B; Ryan C; Naegeli AN; Burge R; Potts Bleakman A; Anatchkova MD; Cather J
    Dermatol Ther (Heidelb); 2018 Mar; 8(1):33-44. PubMed ID: 29204894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS).
    Gottlieb AB; Kirby B; Ryan C; Naegeli AN; Burge R; Potts Bleakman A; Anatchkova MD; Yosipovitch G
    Dermatol Ther (Heidelb); 2018 Mar; 8(1):45-56. PubMed ID: 29204893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study.
    Yosipovitch G; Foley P; Ryan C; Cather JC; Meeuwis KA; Burge R; Bleakman AP; Lin CY; Malatestinic W; Gottlieb A
    J Sex Med; 2018 Nov; 15(11):1645-1652. PubMed ID: 30415816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis.
    Merola JF; Ghislain PD; Dauendorffer JN; Potts Bleakman A; Brnabic AJM; Burge R; Riedl E
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1257-1262. PubMed ID: 31919919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis.
    Ryan C; Menter A; Guenther L; Blauvelt A; Bissonnette R; Meeuwis K; Sullivan J; Cather JC; Yosipovitch G; Gottlieb AB; Merola JF; Callis Duffin K; Fretzin S; Osuntokun OO; Burge R; Naegeli AN; Yang FE; Lin CY; Todd K; Potts Bleakman A;
    Br J Dermatol; 2018 Oct; 179(4):844-852. PubMed ID: 29747232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of genital psoriasis in patients with psoriasis.
    Meeuwis KAP; Potts Bleakman A; van de Kerkhof PCM; Dutronc Y; Henneges C; Kornberg LJ; Menter A
    J Dermatolog Treat; 2018 Dec; 29(8):754-760. PubMed ID: 29565190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning.
    Ryan C; Sadlier M; De Vol E; Patel M; Lloyd AA; Day A; Lally A; Kirby B; Menter A
    J Am Acad Dermatol; 2015 Jun; 72(6):978-83. PubMed ID: 25824273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genital Psoriasis: Impact on Quality of Life and Treatment Options.
    Kelly A; Ryan C
    Am J Clin Dermatol; 2019 Oct; 20(5):639-646. PubMed ID: 31313079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of genital psoriasis on quality of life: a systematic review.
    Yang EJ; Beck KM; Sanchez IM; Koo J; Liao W
    Psoriasis (Auckl); 2018; 8():41-47. PubMed ID: 30214891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis.
    Menter A; Kosinski M; Bresnahan BW; Papp KA; Ware JE
    J Drugs Dermatol; 2004; 3(1):27-38. PubMed ID: 14964744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genital Psoriasis: A Prospective, Observational, Single-Centre Study on Prevalence, Clinical Features, Risk Factors, and Its Impact on Quality of Life and Sexual Health.
    Yi OS; Huan KY; Har LC; Ali NM; Chiang TW
    Indian J Dermatol; 2022; 67(2):205. PubMed ID: 36092244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States.
    Greiling T; Young M; Seal MS; Higham RC; Armstrong A
    Dermatol Ther (Heidelb); 2024 Jul; 14(7):1839-1847. PubMed ID: 38874893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument.
    Lebwohl M; Swensen AR; Nyirady J; Kim E; Gwaltney CJ; Strober BE
    Int J Dermatol; 2014 Jun; 53(6):714-22. PubMed ID: 23557000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity.
    Martin ML; McCarrier KP; Chiou CF; Gordon K; Kimball AB; Van Voorhees AS; Gottlieb AB; Huang X; Globe D; Chau D; Viswanathan HN; Kricorian G
    J Dermatolog Treat; 2013 Aug; 24(4):255-60. PubMed ID: 23249143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling.
    Lewis-Beck C; Abouzaid S; Xie L; Baser O; Kim E
    Patient Prefer Adherence; 2013; 7():199-205. PubMed ID: 23508007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey.
    Reisner DV; Johnsson FD; Kotowsky N; Brunette S; Valdecantos W; Eyerich K
    Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):65-71. PubMed ID: 35061229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and sexual health in patients with genital psoriasis.
    Meeuwis KA; de Hullu JA; van de Nieuwenhof HP; Evers AW; Massuger LF; van de Kerkhof PC; van Rossum MM
    Br J Dermatol; 2011 Jun; 164(6):1247-55. PubMed ID: 21332459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The experience of itch in children with psoriasis: A qualitative exploration of the Itch Numeric Rating Scale.
    Mannix S; Edson-Heredia E; Paller AS; Yosipovitch G; Burge R; Kleinman L
    Pediatr Dermatol; 2021 Mar; 38(2):405-412. PubMed ID: 33336430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
    Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.